Literature DB >> 28509120

Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.

Michio Nagata1, Yutaka Yamaguchi2, Daisuke Toki3, Izumi Yamamoto4, Hiroaki Shinmura5, Hiroshi Kawaguchi5.   

Abstract

The pathogenesis of glomerular hypertension-mediated FSGS and its histological variations in humans remains unknown. A 47-year-old man developed nephrotic syndrome, renal dysfunction, and malignant hypertension 2 years after donating a kidney to his son. The donor's remnant kidney developed renal mass at an upper pole which was fed by an aberrant artery that branched from the root of the renal artery. Furthermore, the main non-aberrant renal artery demonstrated severe stenosis that caused renovascular hypertension, resulting in malignant hypertension. Upon radiological examinations, a tumorous mass was detected. Because of progressive renal dysfunction, nephrectomy was performed. The kidney revealed a diffuse distribution of complex FSGS lesions, i.e., a random combination of cellular/collapsing FSGS and glomerular thrombotic microangiopathy, confined to the renal mass, whereas such lesions were absent in the non-mass portion. This indicated that severe glomerular hypertension alone caused FSGS with TMA features. Heterogeneous FSGS lesions let us surmise that glomerular hypertension promoted simultaneous damages in endothelial cells and podocytes, which synergistically progressed to glomerulosclerosis. This unique case uncovers causal relationships between unusual glomerular hypertension and severe forms of FSGS that was possibly caused by the disruption of homeostasis sustained by podocytes and endothelial cells.

Entities:  

Keywords:  Donor kidney; Focal segmental glomerulosclerosis; Nephrotic syndrome; Renal mass; Renovascular hypertension

Year:  2016        PMID: 28509120      PMCID: PMC5438800          DOI: 10.1007/s13730-016-0235-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  23 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

2.  Renovascular hypertension: a unique cause of unilateral focal segmental glomerulosclerosis.

Authors:  Bassam Alchi; Arimasa Shirasaki; Ichiei Narita; Shinichi Nishi; Mitsuhiro Ueno; Takako Saeki; Shoji Miyamura; Fumitake Gejyo
Journal:  Hypertens Res       Date:  2006-03       Impact factor: 3.872

3.  [A case of renovascular hypertension with nephrotic syndrome, accompanied by focal segmental glomerulosclerosis-like lesion in the contralateral kidney].

Authors:  S Fujii; H Kasahara; H Oguchi
Journal:  Nihon Jinzo Gakkai Shi       Date:  1991-10

4.  Renal artery stenosis and focal segmental glomerulosclerosis in the contralateral kidney.

Authors:  D Bhowmik; S C Dash; D Jain; S K Agarwal; S C Tiwari; A K Dinda
Journal:  Nephrol Dial Transplant       Date:  1998-06       Impact factor: 5.992

5.  Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.

Authors:  Namiko Kobayashi; Toshiharu Ueno; Kumi Ohashi; Hanako Yamashita; Yukina Takahashi; Kazuo Sakamoto; Shun Manabe; Satoshi Hara; Yasutoshi Takashima; Takashi Dan; Ira Pastan; Toshio Miyata; Hidetake Kurihara; Taiji Matsusaka; Jochen Reiser; Michio Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

6.  Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.

Authors:  Satoshi Hara; Namiko Kobayashi; Kazuo Sakamoto; Toshiharu Ueno; Shun Manabe; Yasutoshi Takashima; Juri Hamada; Ira Pastan; Akiyoshi Fukamizu; Taiji Matsusaka; Michio Nagata
Journal:  Am J Pathol       Date:  2015-06-11       Impact factor: 4.307

Review 7.  Pathobiology of focal segmental glomerulosclerosis: new developments.

Authors:  Vivette D D'Agati
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

8.  Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.

Authors:  L D Dworkin; T H Hostetter; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

9.  Focal segmental glomerulosclerosis in malignant hypertension.

Authors:  S Kadiri; J O Thomas
Journal:  S Afr Med J       Date:  2002-04

10.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  3 in total

1.  The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome.

Authors:  Hiroki Mizuno; Naoki Sawa; Shun Watanabe; Daisuke Ikuma; Akinari Sekine; Masahiro Kawada; Masayuki Yamanouchi; Eiko Hasegawa; Tatsuya Suwabe; Junichi Hoshino; Kenmei Takaichi; Keiichi Kinowaki; Takeshi Fujii; Kenichi Ohashi; Michio Nagata; Yutaka Yamaguchi; Yoshifumi Ubara
Journal:  Kidney Int Rep       Date:  2020-05-19

2.  Nephrotic syndrome with focal segmental glomerular lesions unclassified by Columbia classification; Pathology and clinical implication.

Authors:  Takaya Ozeki; Michio Nagata; Takayuki Katsuno; Koji Inagaki; Kazunori Goto; Sawako Kato; Yoshinari Yasuda; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2021-01-05       Impact factor: 3.240

3.  Nephrotic Syndrome Associated with Buerger's Disease.

Authors:  Nahomi Yamaguchi; Akihiro Fukuda; Norihiro Furutera; Miyuki Kimoto; Misaki Maruo; Akiko Kudo; Kohei Aoki; Takeshi Nakata; Noriko Uesugi; Naoya Fukunaga; Hirotaka Shibata
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.